Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian CancerFrancisco José Cândido dos Reis, Julie M. Cunningham, Brooke L. Fridley et al.|Clinical Cancer Research|2014Cited by 160
103P Rate of BRCA1/2 pathogenic variants according to family and personal history of cancer in a large cohort of triple-negative breast cancer (TNBC) patients (pts) younger than 60 years of ageStefania Zovato, Valentina Guarneri, Gaia Griguolo et al.|Annals of Oncology|2021Cited by 1